Gilead Sciences (GILD) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.43.
- Gilead Sciences' EPS (Weighted Average and Diluted) rose 14300.0% to $2.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.45, marking a year-over-year increase of 796250.0%. This contributed to the annual value of $0.38 for FY2024, which is 9144.43% down from last year.
- According to the latest figures from Q3 2025, Gilead Sciences' EPS (Weighted Average and Diluted) is $2.43, which was up 14300.0% from $1.56 recorded in Q2 2025.
- Gilead Sciences' EPS (Weighted Average and Diluted)'s 5-year high stood at $2.43 during Q3 2025, with a 5-year trough of -$3.34 in Q1 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is $0.97, with a median of $1.21 in 2021.
- In the last 5 years, Gilead Sciences' EPS (Weighted Average and Diluted) soared by 390000.0% in 2023 and then plummeted by 51750.0% in 2024.
- Over the past 5 years, Gilead Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at $0.3 in 2021, then skyrocketed by 336.33% to $1.3 in 2022, then decreased by 13.42% to $1.13 in 2023, then rose by 26.15% to $1.42 in 2024, then surged by 71.14% to $2.43 in 2025.
- Its EPS (Weighted Average and Diluted) was $2.43 in Q3 2025, compared to $1.56 in Q2 2025 and $1.04 in Q1 2025.